Identifying anti-growth factors for human cancer cell lines through genome-scale metabolic modeling
Open Access
- 2 February 2015
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 5 (1) , srep08183
Abstract
Human cancer cell lines are used as important model systems to study molecular mechanisms associated with tumor growth, hereunder how genomic and biological heterogeneity found in primary tumors affect cellular phenotypes. We reconstructed Genome scale metabolic models (GEMs) for eleven cell lines based on RNA-Seq data and validated the functionality of these models with data from metabolite profiling. We used cell line-specific GEMs to analyze the differences in the metabolism of cancer cell lines and to explore the heterogeneous expression of the metabolic subsystems. Furthermore, we predicted 85 antimetabolites that can inhibit growth of, or even kill, any of the cell lines, while at the same time not being toxic for 83 different healthy human cell types. 60 of these antimetabolites were found to inhibit growth in all cell lines. Finally, we experimentally validated one of the predicted antimetabolites using two cell lines with different phenotypic origins and found that it is effective in inhibiting the growth of these cell lines. Using immunohistochemistry, we also showed high or moderate expression levels of proteins targeted by the validated antimetabolite. Identified anti-growth factors for inhibition of cell growth may provide leads for the development of efficient cancer treatment strategies.Keywords
This publication has 57 references indexed in Scilit:
- Integration of clinical data with a genome‐scale metabolic model of the human adipocyteMolecular Systems Biology, 2013
- Comparative Proteomic Analysis of Eleven Common Cell Lines Reveals Ubiquitous but Varying Expression of Most ProteinsMolecular & Cellular Proteomics, 2012
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not AnticipateCancer Cell, 2012
- Lipoic Acid Synthetase Deficiency Causes Neonatal-Onset Epilepsy, Defective Mitochondrial Energy Metabolism, and Glycine ElevationThe American Journal of Human Genetics, 2011
- Predicting selective drug targets in cancer through metabolic networksMolecular Systems Biology, 2011
- Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stressGenes & Development, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Integrative genome‐scale metabolic analysis of Vibrio vulnificus for drug targeting and discoveryMolecular Systems Biology, 2011
- Retinoids regulate stem cell differentiationJournal of Cellular Physiology, 2010
- Global reconstruction of the human metabolic network based on genomic and bibliomic dataProceedings of the National Academy of Sciences, 2007